Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse

Journal of Vascular Research

Volumn 37, Issue 2, 2000, Pages 93-102

  Rayner, Kim ^a   Van Eersel, Sander ^a   Groot, Pieter H E ^a   Reape, Theresa J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

ApoE knockout mouse; Atherosclerosis; CCR2; Inflammation; Macrophage; MCP 1 JE

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; GENE EXPRESSION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034030730     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025720     Document Type: Article

References (31)

1. Ross R: Atherosclerosis: A defence mechanism gone awry. Am J Pathol 1993;143:987-1002.
2. Lichtman AH, Cybulsky M, Luscinskas FW: Immunology of atherosclerosis: The promise of mouse models. Am J Pathol 1996;149:351-357.
3. Nakashima Y, Plump AS, Raines EW, Breslow JR, Ross R: Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14:133-140.
4. Zhou X, Stemme S, Hanson KG: Evidence for a local immune response in atherosclerosis - CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 1996;149: 359-366.
5. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362: 801-809.
6. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998;392:565-568.
7. Terkeltaub R, Boisvert WA, Curtis LK: Chemokines and atherosclerosis. Curr Opin Lipidol 1998;9:397-405.
8. Luster AD: Chemokines - Chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
9. Neiken NA, Coughlin SR, Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-1127.
10. Yla-Herttyala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinhurg D: Expression of monocyte chemoattractant protein 1 in macrophage-rich area of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-5256.
11. Takeya M, Yoshimura T, Leonard EJ, Takahashi K: Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993;24: 534-539.
12. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W, Prusty S, Valente AJ, Schwartz CJ, Sonenshein GE: Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992;89:6953-6957.
13. Wysocki SJ, Zheng MH, Smith A, Lamawansa MD, Lacopetta BJ, Robertson TA, Papadimitriou JM, House AK, Normal PE: Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocytes/macrophages. J Cell Biochem 1996;62:10.1-313.
14. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Lihhy P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor deficient mice. Mol Cell 1998;2:275-281.
15. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RB, Broxmeyer HE, Charo IF: Impaired monocyte migration and reduced type I (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2561.
16. Boring L, Gosling J, Cleary M, Charo AF: Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-897.
17. Dawson TC, Kuziel WA, Osahar TA, Maeda N: Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999;143:205-211.
18. Aiello RJ, Bourassa PAK, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM: Monocytc chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vase Biol 1999;19:1518-1525.
19. Isik FF, Coughlin SR, Nelken NA, Clowes AW, Gordon D: JE expression in an animal model of acute arterial graft rejection. J Surg Res 1996;60:224-231.
20. Cochran BH, Reffel AC, Stiles C: Molecular cloning of gene sequences regulated by platelet derived growth factor. Cell 1983;33:939-947.
21. Barrett T, Benditt E: Platelet derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988;85:2810-2814.
22. Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Bunting S, Schwartz SM, Rosenfeld ME: Peripheral vascular stenosis in apolipoprotein E-deficient mice- potential roles of lipid deposition, medial atrophy and adventitial inflammation. Arterioscler Thromb Vasc Biol 1997;17:3593-3601.
23. Wilcox JN, Scott NA: Potential role of the adventitia in artcritis and atherosclerosis, Int J Cardiol 1996;54:S21-S35.
24. Prescott MF, McBride CK, Court M: Development of intimai lesions after leukocyte migration into the vascular wall. Am J Pathol 1989; 135:835-846.
25. Weyland CM, Wagner AD, Björnsson J, Goronzy JJ: Correlation of the topographical arrangement and the functional pattern of tissue infiltrating macrophages in giant cell arteritis. J Clin Invest 1996;98:1642-1649.
26. Han KH, Tangirala RK, Green SR. Quehenberger O: Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1 mediated chemotaxis in human monocytes - a regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol 1998;18:1983-1991.
27. Han KH, Ban KO, Green SR, Quehenberger O: Expression of the monocytc chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: Differential effects of plasma lipoproteins on monocyte function. J Lipid Res 1999;40:1053-1063.
28. Tangirala RK, Murao K, Quehenberger O: Regulation of expression of the human monocyte chemotactic protein receptor (hCCR2) by cytokines. J Biol Chem 1997;272:8050-8056.
29. Zhou YH, Yang Y, Warr G, Bravo R: LPS down-regulates the expression of chemokinc receptor CCR2 in mice and abolishes macrophage infiltration in acute inflammation. J Leukoc Biol 1999;65:265-269.
30. Wong L-M, Myers SJ, Tsou C-L, Gosling J, Arai H, Charo IF: Organisation and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem 1997;272:1038-1045.
31. Vestergaard C, Cesser B, Lohse N, Jensen SL, Sindet-Pedersen S, Thestrup-Pederscn K, Matsushima K, Larsen CG: Monocyte chemotactic and activating factor (MCAF/MCP-1) has an autoinductive effect in monocytes, a process regulated by IL-10. J Dermatol Sci 1997;15: 14-22.